Future studies in an ovarian cancer mouse model may be used to monitor the anti-HSF1-PO4 responses to different therapies for prognostic outcomes, particularly in cases where access to clinical samples may be limited. The gene discussed is HSF1; the disease is ovarian carcinoma.